Insider trading on October 26, 2026
44 insiders at 45 companies bought $71.8M of their own stock on the open market, across 58 transactions. The largest was Venrock Healthcare Capital Partners III, L.P., 10% Owner, buying $35M of Lycia Therapeutics, Inc. (LYCA).
11 chief executives bought: Sweet Julie Spellman at ACN, Williams Charles Alan at NPB, Sweet Julie Spellman at ACN and 8 more.
Insiders sold $79.2M across 171 open-market sales. That is 1.1× the value bought. Selling routinely outweighs buying, because most executive pay is delivered in stock.
Open-market purchases
Code P only — insiders spending their own money, largest first.
Open-market sales
Pre-arranged 10b5-1 trades are marked.